Skip to content

Assessing the Impact of Mixed Exposure to 18 PFASs on Dyslipidemia Risk: An Epidemiological Study in Middle-Aged and Elderly Adults.

Sep 2026 · Environmental Toxicology and Pharmacology · pp. 105175 · 0 citations · 52 references
Medicine

Abstract

Dyslipidemia is a major cardiovascular risk factor, and per- and polyfluoroalkyl substances (PFASs) may disrupt lipid metabolism. This cross-sectional study measured urinary concentrations of 18 PFASs and fasting serum lipids in 214 middle-aged and elderly adults from Guangzhou, China. Associations were assessed using regression models and three mixture approaches: weighted quantile sum regression, quantile g-computation, and Bayesian kernel machine regression, with stratification by sex and age. Twelve PFASs were detected in over 60% of participants, with PFBA and PFPeA showing the highest concentrations. Short-chain PFASs, including PFBA, PFHxA, and PFBS, were positively associated with total cholesterol, triglycerides, and low-density lipoprotein, whereas PFHpA showed inverse associations. 6:2-Cl-PFESA was associated with lower high-density lipoprotein and total cholesterol. Mixture analyses showed no overall association but suggested antagonistic and interactive effects. Associations were stronger in men and adults aged 60-75 years. Prospective studies are needed to clarify causality and mechanisms.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.